About: 肿瘤合并新型冠状病毒感染的临床特征与应对策略

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: 肿瘤合并新型冠状病毒感染的临床特征与应对策略 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	肿瘤合并新型冠状病毒感染的临床特征与应对策略
Creator	Shi, Jie Yang, Shuanying Zeng, Lizhong Zhao, Nannan
source	Medline; PMC
abstract	Since mid-December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has outbroken in Wuhan, Hubei Province, China, and spread rapidly to other provinces in China and dozens of countries and regions around the world, becoming the Public Health Emergency of International Concern (Public Health Emergency of International Concern). SARS-CoV-2 can mainly transmit by droplets or close contact, and is generally susceptible in the crowd. Tumor patients are at high risk of this pathogen because of their impaired immune function. Identifying tumor patients with 2019 novel coronavirus disease (COVID-19) early, and understanding its distribution characteristics can help to improve the cure rate of patients, and better control the epidemic and development of SARS-CoV-2 much better. With comprehensive analysis of relevant literature, this paper reviews the clinical characteristics of neoplastic patients with COVID-19, and puts forward some suggestions on how to deal with this epidemic.
has issue date	2020-04-20(xsd:dateTime)
bibo:doi	10.3779/j.issn.1009-3419.2020.102.15
bibo:pmid	32316713
has license	cc-by
sha1sum (hex)	b1f8aa13029ba3025f27543dd4a18d70f646266f
schema:url	https://doi.org/10.3779/j.issn.1009-3419.2020.102.15
resource representing a document's title	肿瘤合并新型冠状病毒感染的临床特征与应对策略
has PubMed Central identifier	PMC7210081
has PubMed identifier	32316713
schema:publication	Zhongguo Fei Ai Za Zhi
resource representing a document's body	covid:b1f8aa13029ba3025f27543dd4a18d70f646266f#body_text
is schema:about of	named entity 'Chin' named entity 'ARDS' named entity 'Lung Cancer' named entity 'LUNG CANCER' named entity 'Lung Cancer' named entity 'CHIN'
is part of of	covid:b1f8aa13029ba3025f27543dd4a18d70f646266f#body_text 肿瘤合并新型冠状病毒感染的临床特征与应对策略 Since mid-December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has outbroken in Wuhan, Hubei Province, China, and spread rapidly to other provinces in China and dozens of countries and regions around the world, becoming the Public Health Emergency of International Concern (Public Health Emergency of International Concern). SARS-CoV-2 can mainly transmit by droplets or close contact, and is generally susceptible in the crowd. Tumor patients are at high risk of this pathogen because of their impaired immune function. Identifying tumor patients with 2019 novel coronavirus disease (COVID-19) early, and understanding its distribution characteristics can help to improve the cure rate of patients, and better control the epidemic and development of SARS-CoV-2 much better. With comprehensive analysis of relevant literature, this paper reviews the clinical characteristics of neoplastic patients with COVID-19, and puts forward some suggestions on how to deal with this epidemic.

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software